MX2021007538A - Derivados biciclicos. - Google Patents

Derivados biciclicos.

Info

Publication number
MX2021007538A
MX2021007538A MX2021007538A MX2021007538A MX2021007538A MX 2021007538 A MX2021007538 A MX 2021007538A MX 2021007538 A MX2021007538 A MX 2021007538A MX 2021007538 A MX2021007538 A MX 2021007538A MX 2021007538 A MX2021007538 A MX 2021007538A
Authority
MX
Mexico
Prior art keywords
bicyclic derivatives
bicyclic
derivatives
endoparasites
warm
Prior art date
Application number
MX2021007538A
Other languages
English (en)
Inventor
Chouaib Tahtaoui
Francois Pautrat
Pierre Ducray
Denise Rageot
Original Assignee
Elanco Tiergesundheit Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Elanco Tiergesundheit Ag filed Critical Elanco Tiergesundheit Ag
Publication of MX2021007538A publication Critical patent/MX2021007538A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4375—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having nitrogen as a ring heteroatom, e.g. quinolizines, naphthyridines, berberine, vincamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/472—Non-condensed isoquinolines, e.g. papaverine
    • A61K31/4725—Non-condensed isoquinolines, e.g. papaverine containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
    • C07D311/68—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with nitrogen atoms directly attached in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Un dispositivo de limpieza para limpiar un conector que comprende una luz y una superficie roscada interna. El dispositivo de limpieza incluye un cuerpo de limpieza y un cuerpo de émbolo, acoplados de manera operable entre sí. El cuerpo de limpieza incluye una pluralidad de hisopos de limpieza alargados, colocados por separado apartados y en paralelo entre sí. La pluralidad de hisopos de limpieza alargados es rotatoria de manera operable alrededor de una luz de conector, y en acoplamiento desmontable con una superficie roscada interna de conector. El cuerpo de émbolo incluye un tapón alargado para acoplar, de manera desmontable, la luz de conector. El cuerpo de limpieza y el cuerpo de émbolo se acoplan de manera trasladable a lo largo de un eje operacional común. El cuerpo de limpieza y el cuerpo de émbolo se acoplan de manera rotatoria uno respecto a otro alrededor del eje operacional común. El cuerpo de limpieza es una estructura integral.
MX2021007538A 2018-12-18 2019-12-13 Derivados biciclicos. MX2021007538A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201862781073P 2018-12-18 2018-12-18
PCT/US2019/066298 WO2020131629A1 (en) 2018-12-18 2019-12-13 Bicyclic derivatives

Publications (1)

Publication Number Publication Date
MX2021007538A true MX2021007538A (es) 2021-10-13

Family

ID=69143704

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2021007538A MX2021007538A (es) 2018-12-18 2019-12-13 Derivados biciclicos.

Country Status (10)

Country Link
US (1) US20220064160A1 (es)
EP (1) EP3897843A1 (es)
JP (1) JP7304952B2 (es)
CN (1) CN113474044A (es)
AR (1) AR116909A1 (es)
AU (1) AU2019401442B2 (es)
BR (1) BR112021012016A2 (es)
CA (1) CA3122105A1 (es)
MX (1) MX2021007538A (es)
WO (1) WO2020131629A1 (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3897842A1 (en) * 2018-12-18 2021-10-27 Elanco Tiergesundheit AG Bicyclic derivatives
EP3941587A1 (en) 2019-03-19 2022-01-26 Boehringer Ingelheim Animal Health USA Inc. Anthelmintic aza-benzothiophene and aza-benzofuran compounds
CN114206860A (zh) * 2019-06-07 2022-03-18 礼蓝动物保健有限公司 用于治疗体内寄生虫的双环衍生物
TW202120490A (zh) * 2019-07-30 2021-06-01 德商拜耳動物保健有限公司 新穎異喹啉衍生物
MX2022012652A (es) * 2020-04-09 2022-11-10 Bayer Animal Health Gmbh Nuevos compuestos antihelminticos.
MX2022015038A (es) 2020-05-29 2023-01-04 Boehringer Ingelheim Animal Health Usa Inc Compuestos heterociclicos como anthelminticos.
JP2023553269A (ja) 2020-11-18 2023-12-21 エランコ・ティアゲゾンタイト・アーゲー イヌ糸状虫感染症を治療するためのｎ－（２，３－ジヒドロ－１，４－ベンゾオキサジン－４－イル）－３－イソプロピル－７－（２，３，５－トリフルオロフェニル）ベンゾ－チオフェン－２－カルボキサミド誘導体及び類似化合物
TW202237600A (zh) 2020-12-04 2022-10-01 瑞士商禮藍動物保健股份有限公司 雙環衍生物
WO2022122987A1 (en) * 2020-12-11 2022-06-16 Intervet International B.V. Anthelmintic compounds comprising a pyridine structure
WO2023278729A1 (en) * 2021-06-30 2023-01-05 The General Hospital Corporation Chromane imaging ligands
EP4148052A1 (en) * 2021-09-09 2023-03-15 Bayer Animal Health GmbH New quinoline derivatives
CA3236894A1 (en) 2021-11-01 2023-05-04 Boehringer Ingelheim Vetmedica Gmbh Anthelmintic pyrrolopyridazine compounds

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3020793C (en) * 2016-04-15 2024-05-21 Bayer Animal Health Gmbh Pyrazolopyrimidine derivatives
MY196327A (en) 2016-11-11 2023-03-24 Bayer Animal Health Gmbh New Anthelmintic Quinoline-3-Carboxamide Derivative
SG11201909243TA (en) 2017-04-27 2019-11-28 Bayer Animal Health Gmbh New bicyclic pyrazole derivatives
CA3068350A1 (en) 2017-06-30 2019-01-03 Bayer Animal Health Gmbh New azaquinoline derivatives
SG11202000266VA (en) 2017-08-04 2020-02-27 Bayer Animal Health Gmbh Quinoline derivatives for treating infections with helminths

Also Published As

Publication number Publication date
US20220064160A1 (en) 2022-03-03
KR20210106502A (ko) 2021-08-30
CA3122105A1 (en) 2020-06-25
JP7304952B2 (ja) 2023-07-07
JP2022514571A (ja) 2022-02-14
AU2019401442A1 (en) 2021-07-15
WO2020131629A1 (en) 2020-06-25
BR112021012016A2 (pt) 2021-09-08
AR116909A1 (es) 2021-06-23
EP3897843A1 (en) 2021-10-27
AU2019401442B2 (en) 2022-10-20
CN113474044A (zh) 2021-10-01

Similar Documents

Publication Publication Date Title
MX2021007538A (es) Derivados biciclicos.
MX2021007540A (es) Derivados biciclicos.
MY195782A (en) Carbamoyloxymethyl Triazole Cyclohexyl Acids as LPA Antagonists
CL2019000942A1 (es) Compuestos de pirazolo[1,5-a]piridina sustituidos como inhibidores de la quinasa ret.
ZA201906111B (en) Cyclic di-nucleotides compounds for the treatment of cancer
PH12017501413A1 (en) Substituted nucleoside derivatives useful as anticancer agents
CA3010752A1 (en) Inhibitors of the pd-1/pd-l1 protein/protein interaction
PH12018502102A1 (en) Pyrrolotriazine compounds as tam inhibitors
PH12018500408A1 (en) Bicyclic compounds as atx inhibitors
MX2019005277A (es) Composiciones de celulas t con car anti-bcma.
MX2018001430A (es) Nuevos compuestos biciclicos como inhibidores duales de autotaxina (atx)/anhidrasa carbonica (ca).
PH12018500457A1 (en) New phenoxymethyl derivatives
EA201891024A1 (ru) Соединения-ингибиторы tank-связывающей киназы
MX2018001890A (es) Compuestos biciclicos como inhibidores de autotaxina (atx).
MX2018006148A (es) Inhibidores de cxcr2.
PH12018500409A1 (en) New bicyclic compounds as dual atx/ca inhibitors
EA201791305A1 (ru) Конденсированные пиримидины для лечения вич
PH12018501413A1 (en) Substituted thiohydantoin derivatives as androgen receptor antagonists
PH12017502237A1 (en) Nuclear receptor modulators
MX2017016041A (es) Metodos para usar activadores de piruvato cinasa.
BR112021024726A2 (pt) Novos derivados bicíclicos
MX2018012085A (es) Compuestos agonistas de gpr119 y metodo para tratar enfermedades y afecciones mediado a traves de gpr119.
MX2023006606A (es) Derivados biciclicos.
EA201792374A1 (ru) Азабензимидазолы и их применение в качестве модуляторов рецептора ampa
MX2020013630A (es) Analogos de rapamicina y usos de los mismos.